Breakthrough: Major Cause of Inflammatory Bowel Disease Discovered
Researchers at the Francis Crick Institute, UCL, and Imperial College London have identified a new biological pathway involving the gene ETS2 that drives inflammatory bowel disease (IBD). This discovery, published in Nature, reveals that existing MEK inhibitors can potentially reduce inflammation by targeting this pathway, offering hope for better treatments for IBD and related autoimmune conditions.